HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hanna Debiec Selected Research

Membranous Glomerulonephritis (Membranous Nephropathy)

8/2022Contactin 1, a Potential New Antigen Target in Membranous Nephropathy: A Case Report.
7/2022Serum Protein Signatures Using Aptamer-Based Proteomics for Minimal Change Disease and Membranous Nephropathy.
1/2022Recurrence of Anti-Semaphorin 3B-Mediated Membranous Nephropathy after Kidney Transplantation.
12/2021The role of PLA2R antibody monitoring: what we know and what we don't know.
12/2021When contactin antibodies hit the podocyte: a new neurorenal syndrome.
12/2021Contactin-1-associated membranous nephropathy: complete immunologic and clinical remission with rituximab.
7/2021Corrigendum to Berchtold L, Letouzé E, Alexander MP, et al. HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients. Kidney Int. 2021;99:671-685.
7/2021Antenatal Membranous Nephropathy and Type 2 (Axonal) Charcot-Marie-Tooth With Mutations in the Metallo-Membrane Endopeptidase Gene: A Call for Family Screening and Pharmacovigilance.
6/2021Anti-PLA2R1 Antibodies as Prognostic Biomarker in Membranous Nephropathy.
2/2021Advances in Membranous Nephropathy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hanna Debiec Research Topics

Disease

70Membranous Glomerulonephritis (Membranous Nephropathy)
08/2022 - 06/2002
17Proteinuria
01/2022 - 05/2005
9Nephrotic Syndrome (Syndrome, Nephrotic)
01/2022 - 07/2006
5Renal Insufficiency (Renal Failure)
01/2022 - 01/2011
5Chronic Kidney Failure (Chronic Renal Failure)
02/2021 - 10/2004
5Autoimmune Diseases (Autoimmune Disease)
01/2021 - 01/2013
3Lipoid Nephrosis (Glomerulonephritis, Minimal Change)
07/2022 - 02/2017
3Neoplasms (Cancer)
10/2017 - 02/2005
2Disease Progression
12/2021 - 06/2021
2Immune System Diseases (Immune Disorders)
02/2021 - 11/2012
2Infections
02/2017 - 01/2012
2Interstitial Nephritis (Tubulointerstitial Nephritis)
02/2017 - 01/2011
2Sarcoidosis (Schaumann Disease)
06/2015 - 01/2011
2Kidney Neoplasms (Kidney Cancer)
05/2006 - 02/2005
1Disease Susceptibility (Diathesis)
01/2021
1Nephritis
02/2017
1Diabetic Nephropathies (Diabetic Nephropathy)
02/2017
1IGA Glomerulonephritis (IGA Nephropathy)
02/2017
1Collagen Diseases (Collagen Disease)
02/2017
1Mannose-Binding Protein Deficiency
12/2016
1Gambling (Pathological Gambling)
01/2016
1Glomerulonephritis
05/2015
1Glycogen Storage Disease Type II (Pompe's Disease)
04/2014
1Mucopolysaccharidosis VI (Syndrome, Maroteaux-Lamy)
04/2014
1Kidney Diseases (Kidney Disease)
01/2013
1Paraproteinemias (Monoclonal Gammopathy)
07/2010
1Scrapie
11/2009
1Prion Diseases (Transmissible Spongiform Encephalopathies)
11/2009
1Alzheimer Disease (Alzheimer's Disease)
11/2009
1X-Linked Syndrome Enteropathy Polyendocrinopathy Immune Dysregulation
01/2009

Drug/Important Bio-Agent (IBA)

35AntibodiesIBA
06/2021 - 06/2002
27AntigensIBA
08/2022 - 10/2004
18Phospholipase A2 ReceptorsIBA
06/2021 - 04/2010
12Neprilysin (Neutral Endopeptidase)IBA
05/2015 - 06/2002
11Antigen-Antibody Complex (Immune Complex)IBA
02/2021 - 05/2005
10Rituximab (Mabthera)FDA Link
12/2021 - 01/2011
8Proteins (Proteins, Gene)FDA Link
01/2021 - 11/2009
7Complement System Proteins (Complement)IBA
02/2021 - 12/2012
7AutoantibodiesIBA
02/2020 - 02/2011
6Immunoglobulin G (IgG)IBA
01/2021 - 10/2012
5Biomarkers (Surrogate Marker)IBA
12/2021 - 02/2005
5EpitopesIBA
01/2019 - 05/2006
4CreatinineIBA
12/2021 - 12/2012
4AutoantigensIBA
01/2018 - 04/2010
4Bovine Serum AlbuminIBA
08/2017 - 06/2011
4Phospholipases (Phospholipase)IBA
10/2012 - 01/2011
3Semaphorins (Semaphorin)IBA
01/2022 - 11/2020
3ThrombospondinsIBA
01/2019 - 10/2017
3HLA-DQA1 antigen (HLA DQA1)IBA
03/2012 - 02/2011
3Low Density Lipoprotein Receptor-Related Protein-2IBA
07/2011 - 05/2005
2Blood Proteins (Serum Proteins)IBA
07/2022 - 01/2013
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 01/2011
2HLA-D AntigensIBA
07/2021 - 01/2021
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2021 - 01/2018
2SteroidsIBA
02/2021 - 04/2014
2Serum AlbuminIBA
01/2018 - 01/2017
2Phospholipases A2 (Phospholipase A2)IBA
03/2013 - 03/2012
2Immunoglobulins (Immunoglobulin)IBA
07/2010 - 05/2006
2Isoantigens (Alloantigen)IBA
05/2010 - 04/2010
2Peptides (Polypeptides)IBA
11/2009 - 05/2006
2MMEIBA
07/2006 - 10/2004
1Contactin 1IBA
08/2022
1Cell Adhesion MoleculesIBA
12/2021
1EndopeptidasesIBA
07/2021
1Tacrolimus (Prograf)FDA LinkGeneric
02/2021
1Calcineurin InhibitorsIBA
02/2021
1Coloring Agents (Dyes)IBA
01/2021
1Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA
01/2021
1Epidermal Growth Factor (EGF)IBA
01/2020
1Complement Factor H (Factor H)IBA
12/2018
1Amino AcidsFDA Link
11/2018
1Phosphopyruvate Hydratase (Enolase)IBA
02/2017
1LectinsIBA
12/2016
1Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
12/2016
1Codon (Codons)IBA
12/2016
1SulfatasesIBA
04/2014
1Complement Membrane Attack Complex (Membrane Attack Complex)IBA
12/2012
1Double-Stranded RNA (RNA, Double Stranded)IBA
01/2012
1Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2012
1Antiviral Agents (Antivirals)IBA
01/2012
1CytokinesIBA
01/2012
1Toll-Like Receptor 3IBA
01/2012
1ChemokinesIBA
01/2012
1Poly I-CIBA
01/2012
1Viral DNAIBA
01/2012
1ImmunosorbentsIBA
06/2011
1EnzymesIBA
06/2011
1Melphalan (Alkeran)FDA LinkGeneric
07/2010
1Prion ProteinsIBA
11/2009
1PrionsIBA
11/2009
1ThyroglobulinFDA Link
01/2009

Therapy/Procedure

10Therapeutics
01/2022 - 07/2006
4Kidney Transplantation
01/2022 - 10/2004
3Lasers (Laser)
01/2021 - 01/2020
2Transplantation
01/2022 - 01/2021
2Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2009 - 07/2006
1Precision Medicine
02/2021
1Orthopedic Procedures
04/2014
1Enzyme Replacement Therapy
04/2014
1Aftercare (After-Treatment)
01/2011